SPG(SH:600529) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-08-16 06:07Group 1 - The company disclosed information regarding the restructuring of its controlling shareholder, Shandong Luzhong Investment Co., Ltd., which may lead to a change in the indirect controlling shareholder [1][2] - On June 20, 2025, an investment cooperation agreement was signed between China International Pharmaceutical Health Co., Ltd., its Hong Kong subsidiary, and other parties, allowing the former to acquire a 51% stake in Luzhong Investment [1] - The company received a notification on August 15, 2025, confirming that the anti-monopoly review by the State Administration for Market Regulation would not proceed further, allowing the acquisition to move forward [4] Group 2 - The investment from China International and its Hong Kong subsidiary amounts to approximately RMB 244.93 million [4] - The company is actively working to meet the conditions for the effectiveness of the investment cooperation agreement [5] - Relevant documents, including the notification from Luzhong Investment and the anti-monopoly review decision, are available for reference [6][7]